Kolkata: Rubicon Research IPO is designed to mobilise Rs 1,377.50 crore. The bidding process of the IPO began on October 9. It will close today and the price band of the issue has been fixed at Rs 461-485. Rubicon Research is a pharmaceutical company active in development, manufacturing and sale of differentiated formulations. The company was set up in 1999. The company raised Rs 619 crore from anchor investors on October 8, a day before the bidding process got underway.
On June 30, 2025; March 31, 2025; March 31 2024 and March 31 2023 the total income of Rubicon Research stood at Rs 356.95 crore; Rs 1,296.22 crore; Rs 872.39 crore and Rs 419.00 crore respectively. The profit after tax figure on these four dates were Rs 43.30 crore; Rs 134.36 crore; Rs 91.01 crore and Rs (-) 16.89 crore. The total debt stood at Rs 495.78 crore; Rs 393.17 crore’ Rs 396.41 crore and Rs 317.91 crore.
According to the prospectus, on June 30 this year, the company has a portfolio of 72 active abbreviated new drug application (AND) and new drug application products approved by the US FDA. Rubicon Research has 66 commercialized products. Rubicon Research earned $195 million in FY24. On June 30, 2025, Rubicon Research had 17 new products which were waiting for US FDA ANDA approval. Also as many as 63 products were at different stages of development.
Rubicon Research IPO GMP
According to investorgain, Rubicon Research IPO GMP stood at Rs 96 in the morning of October 13. Considering a price band of Rs 485, the inidcate dlisting gain will be 19.79%. However, GMP is an unofficial indicator which changes with time and cannot guarantee any listing gain. However, the gMP of this issue rose from a level ofo Rs 60 on October 4 to Rs 111, the highest level yet, on October 10.
Rubicon Research IPO subscription status
Till the end of the second day of bidding, the Rubicon Research IPO was subscribed 2.49 times overall — 4.16 times in the retail category, 2.22 times in QIB (Ex Anchor) category and 1.92 times in the NII category. Significantly, Ventura Research, a brokerage firm advised investors to apply for Rubicon Research IPO. Venture Research highlighted that the company has a strong R&D base, products that generated high margins and a continuous focus on the US market.
Rubicon Research lot size, allotment
Retail investors have to bid for a minimum lot of 30 shares. The minimum investment required is Rs 14,550 at the upper end of the price band of Rs 461-485. The bNII investors need to bid for at least 14 lots. The Rubicon Research IPO allotment date is October 14 and the stock will list on BSE and NSE on October 16.
(Disclaimer: This article is only meant to provide information. TV9 does not recommend buying or selling shares or subscriptions of any IPO, Mutual Funds, precious metals, commodity, REITs, INVITs, any form of alternative investment instruments and crypto assets.)